Mon, Apr 27 · 8:00

Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery and development of oligonucleotide therapeutics, manufacturing and process development.

View Agenda:

27 April 2019 – Day One (Kick-off Session)
• Turning Challenges to Successes in Peptides Delivery and Formulation

28 April 2020 – Day Two
• Peptide Design, Synthesis, Purification and Analytical Technologies
• Peptide Manufacturing and Process Development
• Oligonucleotide Synthesis, Chemistry, Formulation and Delivery, Process and Analytical Development

29 April 2020 – Day Three
• Peptide Therapeutics: Case Studies, Immunogenicity and Novel Disease Treatments
• Oligonucleotide Therapeutics and Manufacturing

2020 Live Webinar
Targeted, Controlled and Responsive Therapeutic Delivery through the Design of Self-Assembling Peptide Hydrogels
Presented by Aline Miller, Professor, University of Manchester
Tuesday 14th January 2020 | 02:00 PM GMT




General Admission: GBP 520.00

Speakers: Gene Liau, Executive Vice President and Head, Research and Preclinical Development, Stoke Therapeutics, Ekkehard Leberer, Senior Director, Sanofi, Matthew Catley, Research Director, MiNA Therapeutics, Jennifer Franklin, Director, CMC Regulatory Affairs, IONIS Pharmaceuticals, Michael Agrez, Chief Executive Officer, InterK Peptide Therapeutics, David Earp, President and Chief Executive Officer, Circle Pharma, Ali Tavassoli, Founder and Chief Scientific Officer, Curve Therapeutics, Olivier Kitten, Founder and Chief Executive Officer, Affilogic, Alex Batchelor, Chief Executive Officer, Orbit Discovery, Els Beirnaert, Chief Executive Officer, Aelin Therapeutics, Andrew Young, Chief Scientific Officer, Intarcia Therapeutics